| Eyecare Of Claremore-claremore | |
|
221 S Florence Ave, Suite 150, Claremore, OK 74017-8221 | |
| (918) 341-2020 | |
| (918) 341-3888 |
| Full Name | Eyecare Of Claremore-claremore |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 221 S Florence Ave, Claremore, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083654842 | NPI | - | NPPES |
| 200091700A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2161 (Oklahoma) | Primary |
| Provider Name | Eric R Kuykendall |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1144204983 PECOS PAC ID: 7315950599 Enrollment ID: I20060713000161 |
News Archive
When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.
A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.
According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 6 days ago
| Provider Name | Lauren Rachelle Cisper |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255773594 PECOS PAC ID: 7012151764 Enrollment ID: I20130918000723 |
News Archive
When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.
A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.
According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 6 days ago
| Provider Name | Jessica Livermont |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1427785054 PECOS PAC ID: 0042695306 Enrollment ID: I20220922002082 |
News Archive
When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.
A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.
According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 6 days ago
| Provider Name | Nathan Eric Kuykendall |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063192326 PECOS PAC ID: 9234591348 Enrollment ID: I20230821003057 |
News Archive
When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.
A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.
According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eyecare Of Claremore-claremore 221 S Florence Ave, Suite 150, Claremore, OK 74017-8221 Ph: (918) 341-2020 | Eyecare Of Claremore-claremore 221 S Florence Ave, Suite 150, Claremore, OK 74017-8221 Ph: (918) 341-2020 |
News Archive
When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".
This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.
A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.
According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 6 days ago
Dr. Abigail Hogle Fowler, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 860 S Lynn Riggs Blvd, Claremore, OK 74017 Phone: 918-283-2020 Fax: 918-283-2273 | |
Mr. Larry A Riley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1402 N Sioux Ave, Claremore, OK 74017 Phone: 918-341-3284 Fax: 918-341-3127 | |
Nathan Eric Kuykendall, OD Optometrist Medicare: Medicare Enrolled Practice Location: 221 S Florence Ave Ste 150, Claremore, OK 74017 Phone: 918-341-2020 | |
Riley And Riley Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1402 N Sioux Ave, Claremore, OK 74017 Phone: 918-341-3284 Fax: 918-341-3127 | |
Claremore Pryor Eye Clinic P A Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1715 N Lynn Riggs Blvd, Claremore, OK 74017 Phone: 918-342-4222 | |
Mr. Eric Ray Kuykendall, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 221 S Florence Ave, Suite 150, Claremore, OK 74017 Phone: 918-341-2020 Fax: 918-341-3888 |